Business Description
hVIVO PLC
ISIN : GB00B9275X97
Compare
Compare
Traded in other countries / regions
HVO.UKCRO.GermanyHVO.IrelandOPORF.USA IPO Date
2020-03-30Description
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.85 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.34 | |||||
| Debt-to-EBITDA | 0.74 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.29 | |||||
| Beneish M-Score | -1.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 34.1 | |||||
| 3-Year FCF Growth Rate | 53.3 | |||||
| 3-Year Book Growth Rate | 14.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 12.42 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.48 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 100 | |||||
| 14-Day RSI | 100 | |||||
| 12-1 Month Momentum % | 133.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 1.03 | |||||
| Days Inventory | 5.04 | |||||
| Days Sales Outstanding | 52.39 | |||||
| Days Payable | 20.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.69 | |||||
| Dividend Payout Ratio | 0.17 | |||||
| Forward Dividend Yield % | 0.69 | |||||
| 5-Year Yield-on-Cost % | 0.69 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -5.21 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.66 | |||||
| Operating Margin % | 20.72 | |||||
| Net Margin % | 27.1 | |||||
| FCF Margin % | 10.12 | |||||
| ROE % | 55.42 | |||||
| ROA % | 23.52 | |||||
| ROIC % | 30.65 | |||||
| ROC (Joel Greenblatt) % | 97.29 | |||||
| ROCE % | 34.99 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.5 | |||||
| Forward PE Ratio | 16.75 | |||||
| PE Ratio without NRI | 19.5 | |||||
| Price-to-Owner-Earnings | 8.53 | |||||
| PS Ratio | 2.9 | |||||
| PB Ratio | 4.79 | |||||
| Price-to-Tangible-Book | 5.26 | |||||
| Price-to-Free-Cash-Flow | 30.33 | |||||
| Price-to-Operating-Cash-Flow | 14.37 | |||||
| EV-to-EBIT | 11.29 | |||||
| EV-to-Forward-EBIT | 13.78 | |||||
| EV-to-EBITDA | 9.22 | |||||
| EV-to-Forward-EBITDA | 10.93 | |||||
| EV-to-Revenue | 2.51 | |||||
| EV-to-Forward-Revenue | 2.52 | |||||
| EV-to-FCF | 24.77 | |||||
| Price-to-Projected-FCF | 3.07 | |||||
| Price-to-Median-PS-Value | 1.94 | |||||
| Price-to-Graham-Number | 2.3 | |||||
| Price-to-Net-Current-Asset-Value | 36.85 | |||||
| Earnings Yield (Greenblatt) % | 8.86 | |||||
| FCF Yield % | 3.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:OPORF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
hVIVO PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 81.727 | ||
| EPS (TTM) ($) | 0.032 | ||
| Beta | 0.89 | ||
| Volatility % | 120.07 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 0.000683 | ||
| 20-Day SMA ($) | 0.35925 | ||
| 12-1 Month Momentum % | 133.18 | ||
| 52-Week Range ($) | 0.1501 - 0.3685 | ||
| Shares Outstanding (Mil) | 680.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
hVIVO PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
hVIVO PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
hVIVO PLC Frequently Asked Questions
What is hVIVO PLC(OPORF)'s stock price today?
The current price of OPORF is $0.37. The 52 week high of OPORF is $0.37 and 52 week low is $0.15.
When is next earnings date of hVIVO PLC(OPORF)?
The next earnings date of hVIVO PLC(OPORF) is 2025-04-09 Est..
Does hVIVO PLC(OPORF) pay dividends? If so, how much?
The Dividend Yield %  of hVIVO PLC(OPORF) is 0.69% (As of Today), Highest Dividend Payout Ratio of hVIVO PLC(OPORF) was 0.17. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of hVIVO PLC(OPORF) is 0.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers